OPCH · NASDAQ · STOCK
Option Care Health (OPCH) Stock Analysis
$31.08
52W $18.01 – $36.80
57/100
$4.65B
23.4
0.58
Is OPCH Bullish or Bearish?
Bullish.
Innellis AI committee rates Option Care Health (OPCH) Buy with a composite score of 57/100
, based on 6 analysts with 67% agreement.
Last updated October 10, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +18.10 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -1.90 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
Supporting evidence favours the bullish case. The main limiting factor is sector concentration is already high (hhi 2796.97). The committee is constructive but not yet at full conviction.
Bull & Bear Case
Bull Case
- ROE of 15.8% shows genuine earnings power backing the valuation — Value
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- RSI at 91 is in overbought territory — Technical
- Weekly RSI at 81 -- overbought on the larger timeframe too — Technical
- Bollinger bandwidth of 51.0% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 10, 2026
Overall Committee Score
57/100
Agreement
67%
Analysts
6
Conviction
Moderate
Sector Rank
Top 51%
of 192 Healthcare peers
Value Analyst
bullish
63
/ 100 · Moderate confidence
Classic value case: cheap on multiples with earnings power to back it up
+ ROE of 15.8% shows genuine earnings power backing the valuation
Growth Analyst
bullish
62
/ 100 · Moderate confidence
Strong, accelerating growth with consistent execution
+ Quarter-over-quarter growth rate is ACCELERATING, not just positive
Technical Analyst
neutral
54
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
− RSI at 91 is in overbought territory
Risk Analyst
bearish
35
/ 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Bollinger bandwidth of 51.0% signals elevated volatility
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
bullish
62
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
Portfolio Manager
bearish
30
/ 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Investment Thesis Evolution
Committee score moved marginally from 56.9 to 56.9.
- New bearish signals: 1 appeared.
- Bearish pressure eased: 2 signal(s) disappeared.
Analyst-level changes:
- Risk Analyst: +1 bearish signal(s).
Comparing 2026-10-09 to 2026-10-10 (1 day apart).
Technical Analysis
RSI (14)
91.2
Overbought
MACD Histogram
0.954
Bullish Momentum
Trend Direction
Sideways
Weekly: Sideways
Market Structure
Mixed
Support
$30.92
Resistance
$31.43
Bollinger %B
0.98
Inside Bands
Price vs Moving Averages
EMA 9
$27.77
Above
EMA 21
$25.77
Above
EMA 50
$24.46
Above
EMA 200
$25.43
Above
Fundamental Analysis
Valuation
44
Growth
68
Profitability
39
Financial Health
65
Cash Flow
70
Valuation
P/E Ratio
23.4×
P/B Ratio
3.82×
PEG Ratio
4.94
Dividend Yield
0.00%
52W High
$36.80
52W Low
$18.01
Quality & Growth
ROE
1565.0%
ROA
600.7%
Gross Margin
1817.2%
Operating Margin
594.2%
Revenue Growth YoY
—
Debt / Equity
1.01
AI Fundamental Assessment
P/E ratio of 23.4 (inexpensive relative to a 15-40x range); Price-to-book of 3.8x; PEG ratio of 4.9 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 15.7%; Return on assets of 6.0%; Net margin of 3.7%; Gross margin of 18.2%; Current ratio of 1.47 (tight short-term liquidity); Debt-to-equity of 1.01; Free cash flow per share is positive (2.24); Most recent quarter beat estimates by 3.2%; 2 consecutive earnings beats; EPS growth accelerating (-13.0% -> +12.5% QoQ); Average YoY EPS growth of 9.8%; Analyst estimates falling over recent quarters
Get the Full OPCH Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →